These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17196208)

  • 1. Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease--a randomized placebo-controlled study.
    Fernandes JL; de Oliveira RTD; Mamoni RL; Coelho OR; Nicolau JC; Blotta MHSL; Serrano CV
    Atherosclerosis; 2008 Jan; 196(1):434-442. PubMed ID: 17196208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.
    Sliwa K; Woodiwiss A; Kone VN; Candy G; Badenhorst D; Norton G; Zambakides C; Peters F; Essop R
    Circulation; 2004 Feb; 109(6):750-5. PubMed ID: 14970111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F; Polak T; Günther A; Kubuschok B; Janovskaja J; Bitsch A; Poser S; Rieckmann P
    Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials.
    Brie D; Sahebkar A; Penson PE; Dinca M; Ursoniu S; Serban MC; Zanchetti A; Howard G; Ahmed A; Aronow WS; Muntner P; Lip GY; Wong ND; Rysz J; Banach M;
    J Hypertens; 2016 Dec; 34(12):2318-2329. PubMed ID: 27512972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.
    Brown DL; Desai KK; Vakili BA; Nouneh C; Lee HM; Golub LM
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.
    Lauterbach R; Pawlik D; Kowalczyk D; Ksycínski W; Helwich E; Zembala M
    Crit Care Med; 1999 Apr; 27(4):807-14. PubMed ID: 10321674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?
    Macdougall IC
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V73-78. PubMed ID: 15284364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pentoxifylline on inflammatory cytokine expression and acute pleuropneumonia in swine.
    Myers MJ; Baarsch MJ; Murtaugh MP
    Immunobiology; 2002 Mar; 205(1):17-34. PubMed ID: 11999342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria.
    Wenisch C; Looareesuwan S; Wilairatana P; Parschalk B; Vannapann S; Wanaratana V; Wernsdorfer W; Graninger W
    Am J Trop Med Hyg; 1998 Mar; 58(3):343-7. PubMed ID: 9546416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial changes in plasma levels of cytokines in patients with coronary artery disease.
    Heinisch RH; Zanetti CR; Comin F; Fernandes JL; Ramires JA; Serrano CV
    Vasc Health Risk Manag; 2005; 1(3):245-50. PubMed ID: 17319110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume.
    Oliveira-Junior IS; Pinheiro BV; Silva ID; Salomão R; Zollner RL; Beppu OS
    Braz J Med Biol Res; 2003 Oct; 36(10):1349-57. PubMed ID: 14502367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline prevents loss of PP2A phosphatase activity and recruitment of histone acetyltransferases to proinflammatory genes in acute pancreatitis.
    Sandoval J; Escobar J; Pereda J; Sacilotto N; Rodriguez JL; Sabater L; Aparisi L; Franco L; López-Rodas G; Sastre J
    J Pharmacol Exp Ther; 2009 Nov; 331(2):609-17. PubMed ID: 19671881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass.
    Cağli K; Ulaş MM; Ozişik K; Kale A; Bakuy V; Emir M; Balci M; Topbaş M; Sener E; Taşdemir O
    Perfusion; 2005 Jan; 20(1):45-51. PubMed ID: 15751670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages.
    Marcinkiewicz J; Grabowska A; Lauterbach R; Bobek M
    Immunopharmacology; 2000 Sep; 49(3):335-43. PubMed ID: 10996031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study.
    Hemmer CJ; Hort G; Chiwakata CB; Seitz R; Egbring R; Gaus W; Hogel J; Hassemer M; Nawroth PP; Kern P; Dietrich M
    Am J Trop Med Hyg; 1997 Apr; 56(4):397-403. PubMed ID: 9158047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
    Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
    Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
    Liang L; Beshay E; Prud'homme GJ
    Diabetes; 1998 Apr; 47(4):570-5. PubMed ID: 9568689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.